Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06430905
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-17
Brief Title:
Safety Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART
Sponsor:
Hookipa Biotech GmbH
Organization:
Hookipa Biotech GmbH